openPR Logo
Press release

Axial Spondyloarthritis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working

08-10-2022 11:40 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Axial Spondyloarthritis Market

Axial Spondyloarthritis Market

The Axial Spondyloarthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Axial Spondyloarthritis market dynamics.

DelveInsight's "Axial Spondyloarthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Axial Spondyloarthritis, historical and forecasted epidemiology as well as the Axial Spondyloarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Axial Spondyloarthritis Market Report:
• The market size of Axial Spondyloarthritis was estimated at USD 5,594.7 Million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• The total prevalent population of Axial Spondyloarthritis (axSpA ) in the 7MM was 3,981,346
• The highest prevalent cases of Axial Spondyloarthritis (axSpA ) were accounted by the United States in 2021, making up to 2,217,315 cases, while the EU5 countries accounted for 1,751,778 cases in the same year
• The Axial Spondyloarthritis cause is not certain, but the studies show that the cause of Axial Spondyloarthritis is due to the development of unknown genes in the human body which get exposed to the external virus or bacteria
• As per the studies, the prevalence of Axial Spondyloarthritis ranges from 9 to 30 per 10,000 in the general population
• The start of the Axial Spondyloarthritis in most often seen before the age of 45
• The person affected by Axial Spondyloarthritis often suffers chronic back pain with stiffness in the overall body
• Key Axial Spondyloarthritis Companies: Pfizer, Merck, Genrix (Shanghai) Biopharmaceutical, Novartis Pharmaceuticals, UCB, Biopharma, Sharp & Dohme, and others
• Key Axial Spondyloarthritis Therapies: KHK4827, Bimekizumab, Ixekizumab, Secukinumab, Etanercept, Certolizumab, Pegol, and others
• The Axial Spondyloarthritis (axSpA ) epidemiology based on gender analyzed that the prevalent population of AS showed a male predominance, whereas nr-axSpA showed female predominance

Request a sample for the Axial Spondyloarthritis Market Report https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key benefits of the Axial Spondyloarthritis Market report:

1. Axial Spondyloarthritis market report covers a descriptive overview and comprehensive insight of the Axial Spondyloarthritis Epidemiology and Axial Spondyloarthritis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Axial Spondyloarthritis market report provides insights on the current and emerging therapies.
3. Axial Spondyloarthritis market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Axial Spondyloarthritis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Axial Spondyloarthritis market.

Discover more about therapies set to grab major Axial Spondyloarthritis market share @ Axial Spondyloarthritis market forecast - https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Axial Spondyloarthritis Overview
Axial Spondyloarthritis causes severe pain in the joints of the body, stiffness, and fatigue. It is a chronic, inflammatory rheumatic disease that particularly affects the axial skeleton. The actual reason for getting affected with Axial Spondyloarthritis is still unknown but researchers believe that the cause of Axial Spondyloarthritis is due to the development of certain genes in the human body which get exposed to a certain virus, bacteria, or other triggering elements in the environment.
Axial Spondyloarthritis affects the joints and enthuses of the body- tissues that connect bones with the ligaments. Axial Spondyloarthritis can be cured after being diagnosed and properly treated. HLA-B27 likely accounts for about 30% of the overall risk, but numerous other genes work in concert with HLA-B27. Researchers have identified more than 60 genes that are associated with AS and related diseases.

Axial Spondyloarthritis Symptoms
The Axial Spondyloarthritis symptoms include -
• Pain in joints, especially in the ankle, hips, and the knees
• Inflammation in the eye region
• Sleep Problems
• Pain in the heel
• Slow onset chronic back pain

Axial Spondyloarthritis Epidemiology Segmentation:
The Axial Spondyloarthritis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Axial Spondyloarthritis
• Prevalent Cases of Axial Spondyloarthritis by severity
• Gender-specific Prevalence of Axial Spondyloarthritis
• Diagnosed Cases of Episodic and Chronic Axial Spondyloarthritis

Axial Spondyloarthritis Market
The dynamics of the Axial Spondyloarthritis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Etanercept, Certolizumab, and others during the forecasted period 2019-2032.

Download the report to understand which factors are driving Axial Spondyloarthritis epidemiology trends @ Axial Spondyloarthritis Epidemiological Insights - https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Axial Spondyloarthritis Therapies
• KHK4827
• Bimekizumab
• Ixekizumab
• Secukinumab
• Etanercept
• Certolizumab
• Pegol

Axial Spondyloarthritis Key Companies
• Pfizer
• Merck
• Genrix (Shanghai) Biopharmaceutical
• Novartis Pharmaceuticals
• UCB Biopharma
• Sharp & Dohme

Scope of the Axial Spondyloarthritis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Axial Spondyloarthritis Companies: Pfizer, Merck, Genrix (Shanghai) Biopharmaceutical, Novartis Pharmaceuticals, UCB, Biopharma, Sharp & Dohme, and others
• Key Axial Spondyloarthritis Therapies: KHK4827, Bimekizumab, Ixekizumab, Secukinumab, Etanercept, Certolizumab, Pegol, and others
• Therapeutic Assessment: Axial Spondyloarthritis current marketed and Axial Spondyloarthritis emerging therapies
• Migraine Market Dynamics: Axial Spondyloarthritis market drivers and barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Unmet Needs, KOL's views, Analyst's views, Axial Spondyloarthritis Market Access and Reimbursement

Download the report to understand which factors are driving Axial Spondyloarthritis epidemiology trends @ Axial Spondyloarthritis Treatment Assessment - https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Axial Spondyloarthritis Market Drivers
• The introduction of novel products
• Increasing prevalence
• Awareness about the Disease
• Research and development strategies

Axial Spondyloarthritis Market Barriers
• High-cost treatment
• Delay in Diagnosis
• Immunogenicity
• Loss of patent exclusivity
• Availability of generics
• Poor Quality of Life

Table of Contents
1. Axial Spondyloarthritis Market Report Introduction
2. Executive Summary for Axial Spondyloarthritis
3. SWOT analysis of Axial Spondyloarthritis
4. Axial Spondyloarthritis Patient Share (%) Overview at a Glance
5. Axial Spondyloarthritis Market Overview at a Glance
6. Axial Spondyloarthritis Disease Background and Overview
7. Axial Spondyloarthritis Epidemiology and Patient Population
8. Country-Specific Patient Population of Axial Spondyloarthritis
9. Axial Spondyloarthritis Current Treatment and Medical Practices
10. Axial Spondyloarthritis Unmet Needs
11. Axial Spondyloarthritis Emerging Therapies
12. Axial Spondyloarthritis Market Outlook
13. Country-Wise Axial Spondyloarthritis Market Analysis (2019-2032)
14. Axial Spondyloarthritis Market Access and Reimbursement of Therapies
15. Axial Spondyloarthritis Market drivers
16. Axial Spondyloarthritis Market barriers
17. Axial Spondyloarthritis Appendix
18. Axial Spondyloarthritis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Axial Spondyloarthritis treatment, visit @ Axial Spondyloarthritis Medications https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Axial Spondyloarthritis Epidemiology https://www.delveinsight.com/report-store/axial-spondyloarthritis-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Axial Spondyloarthritis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Axial Spondyloarthritis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Diagnostic Imaging Equipment Market
https://www.delveinsight.com/report-store/diagnostic-imaging-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.


Invasive Candidiasis Market
https://www.delveinsight.com/report-store/invasive-candidiasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

"DelveInsight's 'Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.


Sialidosis Market
https://www.delveinsight.com/report-store/sialidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Filgrastim Biosimilar Insight
https://www.delveinsight.com/report-store/filgrastim-biosimilar-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

DelveInsight's, "Filgrastim Biosimilar Insight, 2022," report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.


Pain Management Devices Market
https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027

To know more about our Competitive Services, Click here:
https://www.delveinsight.com/consulting/competitive-intelligence-services?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Axial Spondyloarthritis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working here

News-ID: 2702307 • Views: 304

More Releases from DelveInsight Business Research

Minimal Residual Disease Market is Expected to Expand at a Healthy Growth Rate b …
The Minimal Residual Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Minimal Residual Disease pipeline products will significantly revolutionize the Minimal Residual Disease market dynamics. DelveInsight's "Minimal Residual Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Minimal Residual Disease, historical and forecasted epidemiology as well as the Minimal Residual
Atopic Dermatitis Market to Observe Impressive Growth by (2022-2032), Evaluates …
The Atopic Dermatitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Atopic Dermatitis pipeline products will significantly revolutionize the Atopic Dermatitis market dynamics. DelveInsight's "Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Atopic Dermatitis, historical and forecasted epidemiology as well as the Atopic Dermatitis market trends in the United
Paroxysmal Nocturnal Hemoglobinuria Pipeline Drugs and Companies Insight Report: …
Paroxysmal Nocturnal Hemoglobinuria pipeline constitutes 20+ key companies continuously working towards developing 25+ Paroxysmal Nocturnal Hemoglobinuria treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Paroxysmal Nocturnal Hemoglobinuria Overview Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired (not inherited) disorder that leads to the premature death and impaired production of blood cells. The disorder affects red blood cells (erythrocytes), which carry oxygen; white
Acute Ischemic Stroke Pipeline Drugs and Companies Insight Report: Analysis of C …
Acute Ischemic Stroke pipeline constitutes 35+ key companies continuously working towards developing 35+ Acute Ischemic Stroke treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Acute Ischemic Stroke Overview Acute Ischemic Stroke occurs when blood flow through a brain artery is blocked by a clot- a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within

All 5 Releases